{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:26:05Z","timestamp":1777735565031,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"crossref","award":["HV22C0106"],"award-info":[{"award-number":["HV22C0106"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["National Research Foundation of Korea (NRF)"],"award-info":[{"award-number":["National Research Foundation of Korea (NRF)"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to elucidate the nature and extent of the associations between diabetes mellitus (DM) and migraine through a systematic review and meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched the PubMed, Web of Science, and Scopus databases without a specified start date until June 2, 2024. Cross-sectional and cohort studies analyzing the risk of migraine in individuals with DM and vice versa were included. Studies without at least age and sex adjustments were excluded. Data were extracted to calculate odds ratios (ORs) and hazard ratios (HRs). Risk of bias was assessed using the Newcastle\u2013Ottawa Quality Assessment Scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight cross-sectional studies (131,361 patients with DM and 1,005,604 patients with migraine) and four cohort studies (103,205 patients with DM patients and 32,197 patients with migraine) were included. Meta-analyses of the cross-sectional studies showed no significant overall association between DM and migraine. Subgroup analyses revealed that type 1 diabetes reduced the odds of having migraine (OR 0.48, 95% confidence interval [CI] 0.30\u20130.77), while migraine without aura (MO) increased the odds of having DM (OR 1.19, 95% CI 1.02\u20131.39). The cohort studies indicated that DM decreased the risk of developing migraine (HR 0.83, 95% CI 0.76\u20130.90), and a history of migraine increased the risk of developing DM (HR 1.09, 95% CI 1.01\u20131.17).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>DM, particularly type 1 diabetes, is negatively associated with migraine occurrence, whereas migraine, especially MO, is positively associated with DM occurrence. However, most of the results remained at a low or very low level of evidence, indicating the need for further research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-024-01868-2","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:02:43Z","timestamp":1727449363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Epidemiological linkage between migraine and diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Woo-Seok","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinh Khang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Kyung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"1868_CR1","doi-asserted-by":"publisher","unstructured":"Safiri S, Pourfathi H, Eagan A, Mansournia MA, Khodayari MT, Sullman MJM, Kaufman J, Collins G, Dai H, Bragazzi NL, Kolahi AA (2022) Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain 163(2):e293-e309. https:\/\/doi.org\/10.1097\/j.pain.0000000000002275","DOI":"10.1097\/j.pain.0000000000002275"},{"key":"1868_CR2","doi-asserted-by":"publisher","unstructured":"(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402(10397):203\u2013234. https:\/\/doi.org\/10.1016\/s0140-6736(23)01301-6","DOI":"10.1016\/s0140-6736(23)01301-6"},{"key":"1868_CR3","doi-asserted-by":"publisher","unstructured":"Rainero I, Govone F, Gai A, Vacca A, Rubino E (2018) Is Migraine Primarily a Metaboloendocrine Disorder? Curr Pain Headache Rep 22(5):36. https:\/\/doi.org\/10.1007\/s11916-018-0691-7","DOI":"10.1007\/s11916-018-0691-7"},{"key":"1868_CR4","doi-asserted-by":"publisher","unstructured":"Hosseinpour M, Maleki F, Khoramdad M, Sullman MJM, Nejadghaderi SA, Kolahi AA, Safiri S (2021) A systematic literature review of observational studies of the bilateral association between diabetes and migraine. Diabetes Metab Syndr 15(3):673\u2013678. https:\/\/doi.org\/10.1016\/j.dsx.2021.03.018","DOI":"10.1016\/j.dsx.2021.03.018"},{"key":"1868_CR5","doi-asserted-by":"publisher","unstructured":"Bruijn N, van Lohuizen R, Boron M, Fitzek M, Gabriele F, Giuliani G, Melgarejo L, \u0158ehulka P, Sebastianelli G, Triller P, Vigneri S, \u00d6zcan B, van den Brink AM (2024) Influence of metabolic state and body composition on the action of pharmacological treatment of migraine. J Headache Pain 25(1):20. https:\/\/doi.org\/10.1186\/s10194-024-01724-3","DOI":"10.1186\/s10194-024-01724-3"},{"key":"1868_CR6","doi-asserted-by":"publisher","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA (2022) PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Systematic Reviews 18(2):e1230. https:\/\/doi.org\/10.1002\/cl2.1230","DOI":"10.1002\/cl2.1230"},{"key":"1868_CR7","unstructured":"Wells GA, Shea B, D. OC, J. P, V. W, M. L, P. T (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 2024 Apr 18."},{"key":"1868_CR8","doi-asserted-by":"publisher","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj 336(7650):924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"1868_CR9","doi-asserted-by":"publisher","unstructured":"Minen MT, Weissman J, Tietjen GE (2019) The Relationship Between Migraine or Severe Headache and Chronic Health Conditions: A Cross-Sectional Study from the National Health Interview Survey 2013\u20132015. Pain Med 20(11):2263\u20132271.    https:\/\/doi.org\/10.1093\/pm\/pnz113","DOI":"10.1093\/pm\/pnz113"},{"key":"1868_CR10","doi-asserted-by":"publisher","unstructured":"Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA (2007) Headache prevalence related to diabetes mellitus. The Head-HUNT study. Eur J Neurol 14(7):738\u2013744. https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01765.x","DOI":"10.1111\/j.1468-1331.2007.01765.x"},{"key":"1868_CR11","doi-asserted-by":"publisher","unstructured":"Hagen K, \u00c5svold BO, Midthjell K, Stovner LJ, Zwart JA, Linde M (2018) Inverse relationship between type 1 diabetes mellitus and migraine. Data from the Nord-Tr\u00f8ndelag Health Surveys 1995\u20131997 and 2006\u20132008. Cephalalgia 38(3):417\u2013426. https:\/\/doi.org\/10.1177\/0333102417690488","DOI":"10.1177\/0333102417690488"},{"key":"1868_CR12","doi-asserted-by":"publisher","unstructured":"Berge LI, Riise T, Fasmer OB, Hundal O, Oedegaard KJ, Midthjell K, Lund A (2013) Does diabetes have a protective effect on migraine? Epidemiology 24(1):129\u2013134. https:\/\/doi.org\/10.1097\/EDE.0b013e31827623d0","DOI":"10.1097\/EDE.0b013e31827623d0"},{"key":"1868_CR13","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-de-Andr\u00e9s A, Luis Del Barrio J, Hern\u00e1ndez-Barrera V, de Miguel-D\u00edez J, Jimenez-Trujillo I, Martinez-Huedo MA, Jimenez-Garc\u00eda R (2018) Migraine in adults with diabetes; is there an association? Results of a population-based study. Diabetes Metab Syndr Obes 11:367\u2013374. https:\/\/doi.org\/10.2147\/dmso.S170253","DOI":"10.2147\/dmso.S170253"},{"key":"1868_CR14","doi-asserted-by":"publisher","unstructured":"Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease: a population-based study. Neurology 74(8):628\u2013635. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d0cc8b","DOI":"10.1212\/WNL.0b013e3181d0cc8b"},{"key":"1868_CR15","doi-asserted-by":"publisher","unstructured":"Patel UK, Shah D, Malik P, Hussain M, Chauhan B, Patel D, Sharma S, Khan N, Patel K, Kapoor A, Kavi T (2019) A Comprehensive Assessment of Vascular and Nonvascular Risk Factors Associated with Migraine. Cureus 11(11):e6189. https:\/\/doi.org\/10.7759\/cureus.6189","DOI":"10.7759\/cureus.6189"},{"key":"1868_CR16","doi-asserted-by":"publisher","unstructured":"Schramm S, Tenhagen I, Schmidt B, Holle-Lee D, Naegel S, Katsarava Z, J\u00f6ckel KH, Moebus S (2021) Prevalence and risk factors of migraine and non-migraine headache in older people - results of the Heinz Nixdorf Recall study. Cephalalgia 41(6):649\u2013664. https:\/\/doi.org\/10.1177\/0333102420977183","DOI":"10.1177\/0333102420977183"},{"key":"1868_CR17","doi-asserted-by":"publisher","unstructured":"Antonazzo IC, Riise T, Cortese M, Berge LI, Engeland A, Bernt Fasmer O, Lund A, Joachim \u00d8degaard K, Poluzzi E, Bjornevik K (2018) Diabetes is associated with decreased migraine risk: A nationwide cohort study. Cephalalgia 38(11):1759\u20131764. https:\/\/doi.org\/10.1177\/0333102417748573","DOI":"10.1177\/0333102417748573"},{"key":"1868_CR18","doi-asserted-by":"publisher","unstructured":"Wu J, Fang J, Yuan X, Ma L, Zheng L, Lin Q, An X, Wang Z, Ma Q (2024) Associations of type 2 diabetes and the risk of migraine in Chinese populations. Diabetes Metab 50(2):101518. https:\/\/doi.org\/10.1016\/j.diabet.2024.101518","DOI":"10.1016\/j.diabet.2024.101518"},{"key":"1868_CR19","doi-asserted-by":"publisher","unstructured":"Burch RC, Rist PM, Winter AC, Buring JE, Pradhan AD, Loder EW, Kurth T (2012) Migraine and risk of incident diabetes in women: a prospective study. Cephalalgia 32(13):991\u2013997. https:\/\/doi.org\/10.1177\/0333102412453954","DOI":"10.1177\/0333102412453954"},{"key":"1868_CR20","doi-asserted-by":"publisher","unstructured":"Fagherazzi G, El Fatouhi D, Fournier A, Gusto G, Mancini FR, Balkau B, Boutron-Ruault MC, Kurth T, Bonnet F (2019) Associations Between Migraine and Type 2 Diabetes in Women: Findings From the E3N Cohort Study. JAMA Neurol 76(3):257\u2013263. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3960","DOI":"10.1001\/jamaneurol.2018.3960"},{"key":"1868_CR21","doi-asserted-by":"publisher","unstructured":"Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11(6):521\u2013534. https:\/\/doi.org\/10.1016\/s1474-4422(12)70065-0","DOI":"10.1016\/s1474-4422(12)70065-0"},{"key":"1868_CR22","doi-asserted-by":"publisher","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V (2019) Diabetic neuropathy. Nat Rev Dis Primers 5(1):41. https:\/\/doi.org\/10.1038\/s41572-019-0092-1","DOI":"10.1038\/s41572-019-0092-1"},{"key":"1868_CR23","doi-asserted-by":"publisher","unstructured":"Haanes KA, Edvinsson L (2019) Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets. CNS Drugs 33(6):525\u2013537. https:\/\/doi.org\/10.1007\/s40263-019-00630-6","DOI":"10.1007\/s40263-019-00630-6"},{"key":"1868_CR24","doi-asserted-by":"publisher","unstructured":"Neri LCL, Ferraris C, Catalano G, Guglielmetti M, Pasca L, Pezzotti E, Carpani A, Tagliabue A (2023) Ketosis and migraine: a systematic review of the literature and meta-analysis. Front Nutr 10:1204700. https:\/\/doi.org\/10.3389\/fnut.2023.1204700","DOI":"10.3389\/fnut.2023.1204700"},{"key":"1868_CR25","doi-asserted-by":"publisher","unstructured":"Valente M, Garbo R, Filippi F, Antonutti A, Ceccarini V, Tereshko Y, Di Lorenzo C, Gigli GL (2022) Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes. J Clin Med 11(17). https:\/\/doi.org\/10.3390\/jcm11174946","DOI":"10.3390\/jcm11174946"},{"key":"1868_CR26","doi-asserted-by":"publisher","unstructured":"Lu G, Xiao S, Meng F, Zhang L, Chang Y, Zhao J, Gao N, Su W, Guo X, Liu Y, Li C, Tang W, Zou L, Yu S, Liu R (2024) AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization. J Headache Pain 25(1):29. https:\/\/doi.org\/10.1186\/s10194-024-01739-w","DOI":"10.1186\/s10194-024-01739-w"},{"key":"1868_CR27","doi-asserted-by":"publisher","unstructured":"Jing F, Zou Q, Pu Y (2023) GLP-1R agonist liraglutide attenuates pain hypersensitivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model. Neurosci Lett 812:137397. https:\/\/doi.org\/10.1016\/j.neulet.2023.137397","DOI":"10.1016\/j.neulet.2023.137397"},{"key":"1868_CR28","doi-asserted-by":"publisher","unstructured":"Halloum W, Dughem YA, Beier D, Pellesi L (2024) Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review. J Headache Pain 25(1):112. https:\/\/doi.org\/10.1186\/s10194-024-01821-3","DOI":"10.1186\/s10194-024-01821-3"},{"key":"1868_CR29","doi-asserted-by":"publisher","unstructured":"Saisho Y (2015) Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. Endocr Metab Immune Disord Drug Targets 15(3):196\u2013205. https:\/\/doi.org\/10.2174\/1871530315666150316124019","DOI":"10.2174\/1871530315666150316124019"},{"key":"1868_CR30","doi-asserted-by":"publisher","unstructured":"Xie D, Wang Q, Huang W, Zhao L (2023) Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes. Eur J Clin Pharmacol 79(10):1291\u20131301. https:\/\/doi.org\/10.1007\/s00228-023-03541-0","DOI":"10.1007\/s00228-023-03541-0"},{"key":"1868_CR31","doi-asserted-by":"publisher","unstructured":"Scisciola L, Cataldo V, Taktaz F, Fontanella RA, Pesapane A, Ghosh P, Franzese M, Puocci A, De Angelis A, Sportiello L, Marfella R, Barbieri M (2022) Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials. Front Cardiovasc Med 9:1008922. https:\/\/doi.org\/10.3389\/fcvm.2022.1008922","DOI":"10.3389\/fcvm.2022.1008922"},{"key":"1868_CR32","doi-asserted-by":"publisher","unstructured":"Ha WS, Chu MK (2024) Altered immunity in migraine: a comprehensive scoping review. J Headache Pain 25(1):95. https:\/\/doi.org\/10.1186\/s10194-024-01800-8","DOI":"10.1186\/s10194-024-01800-8"},{"key":"1868_CR33","doi-asserted-by":"publisher","unstructured":"Wium-Andersen IK, Osler M, J\u00f8rgensen MB, Rungby J, Wium-Andersen MK (2022) Diabetes, antidiabetic medications and risk of depression - A population-based cohort and nested case-control study. Psychoneuroendocrinology 140:105715. https:\/\/doi.org\/10.1016\/j.psyneuen2022.105715","DOI":"10.1016\/j.psyneuen2022.105715"},{"key":"1868_CR34","doi-asserted-by":"publisher","unstructured":"Wada J, Makino H (2016) Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol 12(1):13\u201326. https:\/\/doi.org\/10.1038\/nrneph.2015.175","DOI":"10.1038\/nrneph.2015.175"},{"key":"1868_CR35","doi-asserted-by":"publisher","unstructured":"Rehman K, Akash MS (2016) Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci 23(1):87. https:\/\/doi.org\/10.1186\/s12929-016-0303-y","DOI":"10.1186\/s12929-016-0303-y"},{"key":"1868_CR36","doi-asserted-by":"publisher","unstructured":"Berk M, Williams LJ, Jacka FN, O\u2019Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200. https:\/\/doi.org\/10.1186\/1741-7015-11-200","DOI":"10.1186\/1741-7015-11-200"},{"key":"1868_CR37","doi-asserted-by":"publisher","unstructured":"Lee CH, Giuliani F (2019) The Role of Inflammation in Depression and Fatigue. Front Immunol 10:1696. https:\/\/doi.org\/10.3389\/fimmu.2019.01696","DOI":"10.3389\/fimmu.2019.01696"},{"key":"1868_CR38","doi-asserted-by":"publisher","unstructured":"Zhang H, Dhalla NS (2024) The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease. Int J Mol Sci 25(2). https:\/\/doi.org\/10.3390\/ijms25021082","DOI":"10.3390\/ijms25021082"},{"key":"1868_CR39","doi-asserted-by":"publisher","unstructured":"Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52(7):1799\u20131805. https:\/\/doi.org\/10.2337\/diabetes.52.7.1799","DOI":"10.2337\/diabetes.52.7.1799"},{"key":"1868_CR40","doi-asserted-by":"publisher","unstructured":"Golubic R, Hussein Ismail M, Josipovic M, Kennet J, Galderisi A, Evans ML (2023) Sumatriptan, a serotonin 5HT(1B) receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double-blinded placebo-controlled cross-over trial. Diabetes Obes Metab 25(10):3059\u20133063. https:\/\/doi.org\/10.1111\/dom.15176","DOI":"10.1111\/dom.15176"},{"key":"1868_CR41","doi-asserted-by":"publisher","unstructured":"Sun JW, Young JG, Sarvet AL, Bailey LC, Heerman WJ, Janicke DM, Lin PD, Toh S, Block JP (2022) Comparison of Rates of Type 2 Diabetes in Adults and Children Treated With Anticonvulsant Mood Stabilizers. JAMA Netw Open 5(4):e226484. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.6484","DOI":"10.1001\/jamanetworkopen.2022.6484"},{"key":"1868_CR42","doi-asserted-by":"publisher","unstructured":"Islam MR, Nyholt DR (2022) Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration. Genes (Basel) 13(5). https:\/\/doi.org\/10.3390\/genes13050730","DOI":"10.3390\/genes13050730"},{"key":"1868_CR43","doi-asserted-by":"publisher","unstructured":"Siewert KM, Klarin D, Damrauer SM, Chang KM, Tsao PS, Assimes TL, Davey Smith G, Voight BF (2020) Cross-trait analyses with migraine reveal widespread pleiotropy and suggest a vascular component to migraine headache. Int J Epidemiol 49(3):1022\u20131031. https:\/\/doi.org\/10.1093\/ije\/dyaa050","DOI":"10.1093\/ije\/dyaa050"},{"key":"1868_CR44","doi-asserted-by":"publisher","unstructured":"Xue H, Zeng L, Liu S (2023) Unraveling the link: exploring the causal relationship between diabetes, multiple sclerosis, migraine, and Alzheimer\u2019s disease through Mendelian randomization. Front Neurosci 17:1233601. https:\/\/doi.org\/10.3389\/fnins.2023.1233601","DOI":"10.3389\/fnins.2023.1233601"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01868-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:02:45Z","timestamp":1727449365000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01868-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1868"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01868-2","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WSH serves as junior editor of <i>The Journal of Headache and Pain<\/i>.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"VKN has no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"MKC serves as a board member of <i>The Journal of Headache and Pain<\/i>. MKC was the site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and the Ildong Pharmaceutical Company. He has received lecture honoraria from Eli Lilly and Company, Handok-Teva, and the Ildong Pharmaceutical Company over the past 24 months. He received grants from the Yonsei University College of Medicine (6-2021-0229), the Korea Health Industry Development Institute (KHIDI) (HV22C0106), and an NRF grant from the Korean government (MSIT) (2022R1A2C1091767).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}